companydata.dkcompanydata.dk

Pharmaway Invest ApS: Financial statements 2018

CVR: 38585126

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -4,375 and a net result of DKK -6,266. Equity in the 2018 report amounted to DKK 33,863,109. The solvency ratio was 99.6%.

Gross Profit
DKK -4,375
Profit/Loss
DKK -6,266
Equity
DKK 33,863,109
Total Assets
DKK 34,000,000

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Pharmaway Invest ApS publishes interim reportJun 12, 2018

Pharmaway Invest ApS has published its interim report for the period April 21, 2017 to December 31, 2017.

About Pharmaway Invest ApS

Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.

Source: annual report 2025, Danish Business Authority

Other financial years